Spo Global Inc. logo

Spo Global Inc. (SPOM)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
69.29K Market Cap
- P/E Ratio
- Div Yield
2,300 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track SPOM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SPOM closed Monday higher at $0, an increase of 0% from Friday's close, completing a monthly increase of 36.3636% or $0. Over the past 12 months, SPOM stock lost -40%.
SPOM is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2016, missed the consensus estimates by -5.228%. On average, the company has fell short of earnings expectations by -9.2476%, based on the last three reports.
Spo Global Inc. has completed 4 stock splits, with the recent split occurring on Jul 26, 2018.
The company's stock is traded on one exchange.

SPOM Chart

People also search for

WM Technology, Inc.
$ 0.41
+1.2195%
Realbotix Corp.
$ 0.22
+4.8333%
Luna Innovations Incorporated
$ 1.27
0%
Marpai Inc.
$ 2.16
-1.3699%
Argo Corp.
$ 0.24
-0.6723%

Spo Global Inc. (SPOM) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Spo Global Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is SPOM.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 69.29K.

Has Spo Global Inc. ever had a stock split?

Spo Global Inc. had 4 splits and the recent split was on Jul 26, 2018.

Spo Global Inc. Profile

Software Industry
Information Technology Sector
Fengyou Lu CEO
OTC PINK Exchange
78468T206 CUSIP
US Country
7 Employees
- Last Dividend
7 Oct 2013 Last Split
- IPO Date

Overview

Gerpang Healthcare Group is a bio-pharmaceutical company based in Jinan, China, since its inception in 2006. The company specializes in the development, manufacture, and sale of a wide range of bio-pharmaceutical products. With a strong focus on innovation and quality, Gerpang Healthcare Group aims to address various medical and health needs through its diverse portfolio, including genetic coating stents, vaccines, monoclonal antibodies, functional food, and probiotics.

Products and Services

  • Genetic Coating Stents
  • These are advanced medical devices used in the treatment of coronary artery diseases. Genetic coating stents released by Gerpang Healthcare Group are designed to improve the compatibility and efficacy of stent implantations, reducing the risk of complications and promoting faster healing.

  • HBV Hepatitis B Virus Vaccines
  • Gerpang Healthcare Group has developed vaccines aimed at preventing infection with the Hepatitis B virus. These vaccines are a critical component of public health efforts to reduce the incidence of HBV-related diseases, including chronic hepatitis, cirrhosis, and liver cancer.

  • Monoclonal Antibodies for Male Infertility Detection
  • These products represent a breakthrough in the diagnosis and treatment of male infertility. Gerpang Healthcare Group's monoclonal antibodies are used to detect specific infertility-related conditions in men, aiding in accurate diagnosis and tailored treatments.

  • Cognitive Disorder Functional Food
  • Addressing the growing concern of cognitive disorders, Gerpang Healthcare Group offers functional food products designed to support cognitive health. These foods are enriched with nutrients and compounds that contribute to brain health, potentially improving memory, focus, and other cognitive functions.

  • Polypeptide Probiotics
  • The company also deals in polypeptide probiotics, which are aimed at improving gut health and overall well-being. These probiotics are formulated to enhance digestive health, boost the immune system, and provide other health benefits through the modulation of gut flora.

Contact Information

Address: 6343 All American Boulevard
Phone: 86 53 1587 08846